Formed in 1991, and situated on the Wirral, UK, Phoenix is recognised around the world as a leader in applying continuous processing technology to fine chemicals manufacture, providing innovative yet practical solutions for many of today’s leading pharmaceutical companies.
Most chemical reactions are tailored to suit batch operations. This often precludes what would arguably be better, more direct chemical routes. At Phoenix we engineer the plant to suit the chemistry, an approach that can revolutionise chemical synthesis.
Through the application of continuous processing technology, we now regularly handle a variety of difficult or hazardous chemistries at production scale, including:
High pressure hydrogenations
Asymmetric reductions
Chloromethylations
Catalytic oxidations
Diazomethane
Chloramine
Cyanide
Azides, incl hydrazoic acid
Hydrazine
Bromine
Nitromethane
Using small-scale continuous processing techniques, our ‘desk-top’ sized production units can be tailored to produce anything from grams to kilos, through to multi-tonne, commercial quantities.
The benefits of this approach are seen in an improved product quality, enhanced yields, increased process safety, shorter lead-times and lower manufacturing costs.
